Schizophrenia - atypical antipsychotics (replaced by CG82)
The clinical effectiveness and cost effectiveness of newer atypical antipsychotic drugs for schizophrenia
Summary
This guidance has been updated and replaced by CG82 Schizophrenia. NICE has made the following recommendations: Doctors should discuss with the individual which antipsychotic drug to take. The decision about which drugs are prescribed should be made jointly, after the doctor has explained the bene ...
Guidance documents
Implementing this guidance
About this guidance
Technology appraisals TA43
Issued: June 2002